OpenAlex
PricingAboutJobs
Log inGet started
Work

Targeting the MUC1-C oncoprotein downregulates HER2 activation and abrogates trastuzumab resistance in breast cancer cells

HTML

Year: 2013
Type: article
Source: Oncogene
DOI: 10.1038/onc.2013.308
Authors: D Raina, Y Uchida, A Kharbanda, H Rajabi, G Panchamoorthy, C Jin, S Kharbanda, M Scaltriti, J Baselga, D Kufe
Institutions: Harvard University, Dana-Farber Cancer Institute, Genus Oncology (United States), Memorial Sloan Kettering Cancer Center
Language: English

Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: MUC1-C, HER2, trastuzumab resistance, HER2-positive breast cancer, Akt activation, p27, cyclin E, combination therapy, SKBR3, BT474 cells, tyrosine phosphorylation
SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute
Awards: MUC1-C Oncoprotein Evades Immune Destruction in Non-small Cell Lung Cancer, Targeting the MUC1-C Oncoprotein in Triple-Negative Breast Cancer
OpenAlex ID: W2012204343
FWCI: 4.609
Cites: 50
Cited by: 115
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security